JP2000262591A - Liquid container - Google Patents
Liquid containerInfo
- Publication number
- JP2000262591A JP2000262591A JP11069315A JP6931599A JP2000262591A JP 2000262591 A JP2000262591 A JP 2000262591A JP 11069315 A JP11069315 A JP 11069315A JP 6931599 A JP6931599 A JP 6931599A JP 2000262591 A JP2000262591 A JP 2000262591A
- Authority
- JP
- Japan
- Prior art keywords
- container
- needle
- liquid
- liquid container
- shaped tube
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 38
- 239000000126 substance Substances 0.000 claims description 17
- 239000004033 plastic Substances 0.000 claims description 7
- 229920003023 plastic Polymers 0.000 claims description 7
- 238000001802 infusion Methods 0.000 abstract description 13
- 238000002156 mixing Methods 0.000 abstract description 2
- 239000011347 resin Substances 0.000 abstract description 2
- 229920005989 resin Polymers 0.000 abstract description 2
- 239000012530 fluid Substances 0.000 abstract 3
- 239000000243 solution Substances 0.000 description 26
- 239000003814 drug Substances 0.000 description 11
- 229940079593 drug Drugs 0.000 description 9
- VXNZUUAINFGPBY-UHFFFAOYSA-N 1-Butene Chemical compound CCC=C VXNZUUAINFGPBY-UHFFFAOYSA-N 0.000 description 6
- 210000003811 finger Anatomy 0.000 description 6
- -1 polyethylene Polymers 0.000 description 6
- 229920001577 copolymer Polymers 0.000 description 5
- 239000004698 Polyethylene Substances 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 229920000573 polyethylene Polymers 0.000 description 3
- 229920000098 polyolefin Polymers 0.000 description 3
- WSSSPWUEQFSQQG-UHFFFAOYSA-N 4-methyl-1-pentene Chemical compound CC(C)CC=C WSSSPWUEQFSQQG-UHFFFAOYSA-N 0.000 description 2
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 2
- 239000005977 Ethylene Substances 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- 229920000669 heparin Polymers 0.000 description 2
- 229920001519 homopolymer Polymers 0.000 description 2
- 239000003978 infusion fluid Substances 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- YWAKXRMUMFPDSH-UHFFFAOYSA-N pentene Chemical compound CCCC=C YWAKXRMUMFPDSH-UHFFFAOYSA-N 0.000 description 2
- WEXRUCMBJFQVBZ-UHFFFAOYSA-N pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 229940071643 prefilled syringe Drugs 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- KWKAKUADMBZCLK-UHFFFAOYSA-N 1-octene Chemical compound CCCCCCC=C KWKAKUADMBZCLK-UHFFFAOYSA-N 0.000 description 1
- 101100160821 Bacillus subtilis (strain 168) yxdJ gene Proteins 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 229920000089 Cyclic olefin copolymer Polymers 0.000 description 1
- 239000004713 Cyclic olefin copolymer Substances 0.000 description 1
- CTENFNNZBMHDDG-UHFFFAOYSA-N Dopamine hydrochloride Chemical compound Cl.NCCC1=CC=C(O)C(O)=C1 CTENFNNZBMHDDG-UHFFFAOYSA-N 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- BGSOJVFOEQLVMH-UHFFFAOYSA-N Hydrocortisone phosphate Natural products O=C1CCC2(C)C3C(O)CC(C)(C(CC4)(O)C(=O)COP(O)(O)=O)C4C3CCC2=C1 BGSOJVFOEQLVMH-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- HCBIBCJNVBAKAB-UHFFFAOYSA-N Procaine hydrochloride Chemical compound Cl.CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 HCBIBCJNVBAKAB-UHFFFAOYSA-N 0.000 description 1
- ABBQHOQBGMUPJH-UHFFFAOYSA-M Sodium salicylate Chemical compound [Na+].OC1=CC=CC=C1C([O-])=O ABBQHOQBGMUPJH-UHFFFAOYSA-M 0.000 description 1
- 102100031083 Uteroglobin Human genes 0.000 description 1
- 108090000203 Uteroglobin Proteins 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 239000003130 blood coagulation factor inhibitor Substances 0.000 description 1
- 229910001622 calcium bromide Inorganic materials 0.000 description 1
- WGEFECGEFUFIQW-UHFFFAOYSA-L calcium dibromide Chemical compound [Ca+2].[Br-].[Br-] WGEFECGEFUFIQW-UHFFFAOYSA-L 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- BGSOJVFOEQLVMH-VWUMJDOOSA-N cortisol phosphate Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)COP(O)(O)=O)[C@@H]4[C@@H]3CCC2=C1 BGSOJVFOEQLVMH-VWUMJDOOSA-N 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229960001149 dopamine hydrochloride Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- ZFGMDIBRIDKWMY-PASTXAENSA-N heparin Chemical compound CC(O)=N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COS(O)(=O)=O)O[C@@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O[C@H]2[C@@H]([C@@H](OS(O)(=O)=O)[C@@H](O[C@@H]3[C@@H](OC(O)[C@H](OS(O)(=O)=O)[C@H]3O)C(O)=O)O[C@@H]2O)CS(O)(=O)=O)[C@H](O)[C@H]1O ZFGMDIBRIDKWMY-PASTXAENSA-N 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 229950000785 hydrocortisone phosphate Drugs 0.000 description 1
- 230000000297 inotrophic effect Effects 0.000 description 1
- 239000002960 lipid emulsion Substances 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 229960005015 local anesthetics Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 229960002289 nicardipine hydrochloride Drugs 0.000 description 1
- AIKVCUNQWYTVTO-UHFFFAOYSA-N nicardipine hydrochloride Chemical compound Cl.COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)CC=2C=CC=CC=2)C1C1=CC=CC([N+]([O-])=O)=C1 AIKVCUNQWYTVTO-UHFFFAOYSA-N 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- 229960001412 pentobarbital Drugs 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 229960001309 procaine hydrochloride Drugs 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 229940125723 sedative agent Drugs 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 238000009751 slip forming Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229960004025 sodium salicylate Drugs 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 229920006132 styrene block copolymer Polymers 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 210000003813 thumb Anatomy 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000004711 α-olefin Substances 0.000 description 1
Landscapes
- Containers Opened By Tearing Frangible Portions (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は内容液を他に注入す
るための針状管部が突出された液体容器に関するもので
あり、特に針状管部の先端部を改良した液体容器に関す
るものである。本発明は、例えば輸液投与時に他の薬液
の混注する場合に使用すれば特に有効である。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a liquid container having a protruding needle-like tube for injecting a content liquid into the liquid container, and more particularly to a liquid container having an improved distal end portion of the needle-like tube. is there. The present invention is particularly effective when used, for example, when another drug solution is co-injected during infusion administration.
【0002】[0002]
【従来の技術】輸液に他の薬剤、例えばビタミン剤や微
量元素製剤、ヘパリン等を配合して投与されることが多
いが、配合後保管中に変質する等の理由で配合済みの製
品にできない場合には、個別の製剤をその都度注射器等
で取り出し、これを輸液容器や点滴経路の側管より注入
して配合するのが通例である。しかし、上記操作は、煩
雑な上に汚染の機会も多いので、混注操作を簡素化する
目的で、針等の注入部を備えた容器に予め一回投与分の
薬液の収容するようにした薬液容器が種々提案されてい
る。そのような薬液容器としては、例えば薬液を注射器
の中に収容したいわゆるプレフィルドシリンジの他に、
特公昭61−2380号公報の第1図〜第4図に記載さ
れたものや、特開平8−299437号公報に記載され
たもの等がある。2. Description of the Related Art Infusions are often administered with other drugs, such as vitamins, trace element preparations, heparin, etc., but cannot be converted into pre-mixed products due to deterioration during storage after mixing. In such a case, it is customary to take out the individual formulation with a syringe or the like each time and inject the formulation from an infusion container or a side tube of an infusion route to mix. However, the above operation is complicated and there are many opportunities for contamination. Therefore, for the purpose of simplifying the co-injection operation, a drug solution in which a single dose of drug solution is previously stored in a container provided with an injection unit such as a needle is used. Various containers have been proposed. As such a drug solution container, for example, in addition to a so-called prefilled syringe containing a drug solution in a syringe,
FIGS. 1 to 4 of JP-B-61-2380, and those described in JP-A-8-29937.
【0003】[0003]
【発明が解決しようとする課題】ところが、上記 プレ
フィルドシリンジや特公昭61−2380号公報記載の
タイプのものは、金属針を備えているので、人体に直接
投与するにはよいが、廃棄の点で問題点がある。特開平
8−299437号公報記載のものは、全体がプラスチ
ックで形成されており、焼却処分が可能な点で有利であ
るが、点滴経路の側管(ルアーコネクター)にしか適合
しない形状なので、用途が限定されてしまうという問題
点がある。本発明はこのような事情を背景としてなされ
たものであり、本発明の目的は、輸液等の液体に他の薬
液等の液体を配合する際、輸液容器等の容器や点滴経路
の側管に薬液等の液体を注入できるようにした液体容器
と、焼却処分が可能な液体容器を提供することである。However, the pre-filled syringe and the type described in Japanese Patent Publication No. 61-2380 are equipped with a metal needle, so that they can be administered directly to the human body. There is a problem. Japanese Patent Application Laid-Open No. Hei 8-29937 is advantageous because it is entirely formed of plastic and can be incinerated, but has a shape that is compatible only with the side tube (luer connector) of the drip route. Is limited. The present invention has been made in view of such circumstances, and an object of the present invention is to mix a liquid such as an infusion solution with a liquid such as another medicinal solution when using a container such as an infusion container or a side tube of an infusion route. An object of the present invention is to provide a liquid container capable of injecting a liquid such as a chemical solution and a liquid container capable of being incinerated.
【0004】[0004]
【課題を解決するための手段】このような目的を達成す
るためになされた本発明は、次のように構成される。 A 内容液の流通可能な流通路を有する針状管部が突出
された液体容器において、前記針状管部は先端部が先鋭
な形状をなし、かつ前記流通路の先端部は薄肉部によっ
て閉塞されると共に薄肉部には指で把持し得る把持片が
一体に形成されてなり、把持片を動かすことによって前
記薄肉部を破損し、流通路を開封させ得るようにしたこ
とを特徴とする液体容器。 B 前記A項記載の液体容器において、液体容器自体は
プラスチックで一体に構成するようにした液体容器。 C 前記A項もしくはB項記載の液体容器において、収
容される液体が薬液である液体容器。Means for Solving the Problems The present invention made to achieve such an object is constituted as follows. A In a liquid container having a protruding needle-like tubular portion having a flow passage through which a content liquid can flow, the needle-like tubular portion has a sharp tip, and the distal end of the flow passage is closed by a thin portion. A liquid is characterized in that a gripping piece that can be gripped by a finger is formed integrally with the thin part, and the thin part is damaged by moving the gripping piece, so that the flow passage can be opened. container. B. The liquid container according to the above A, wherein the liquid container itself is made of plastic and integrally formed. C. The liquid container according to the above A or B, wherein the contained liquid is a chemical.
【0005】[0005]
【発明の実施の形態】以下本発明の実施例を記載した図
面に基づいて、発明の実施の形態を詳細に説明する。図
1〜図2は実施例の薬液容器を拡大して図示している。
同図において8は液体容器としての薬液容器であり、プ
ラスチックで一体に構成されている。薬液を収容する容
器本体部10の上端側には針状管部12が連設され、針
状管部12内部の流通路14を介して輸液容器や点滴経
路の側管等に薬液を注入できるようにされている。針状
管部12の中間部に形成された取手部16と容器本体部
10との間には針状管部12の両側の対象位置に肉の薄
い補強リブ18が一体に設けられている。針状管部12
の先端部は鋭角をなすように切り取られたような形状を
なし、特にその最先端部分は図3(ロ)に示すように三
角錐状の先鋭な形状をなしている。針状管部12内の流
通路14の先端部には、図3(イ)に示すように薄肉部
20が形成され、流通路14が閉塞されている。そし
て、薄肉部20の外側には、薄板状の把持片22が、図
3(ロ)に示すような断面が円形状の先端部分で一体に
連設され、把持片22をねじったり、左右や上下あるい
は斜め等に動かすことによって薄肉部20を破損し、流
通路14を開封できるようにされている。なお、薬液容
器には、製造時薬液が充填されるが、容器本体部10は
指で押しつぶすことにより内容液を排出できるようにさ
れている。薬液容器の製造は、容器の成形、薬液の充
填、溶閉を連続的に行う、いわゆるブローフィルシール
法によって無菌状態で能率よく行うことが可能である。Embodiments of the present invention will be described below in detail with reference to the drawings illustrating embodiments of the present invention. 1 and 2 show an enlarged view of the chemical solution container of the embodiment.
In the figure, reference numeral 8 denotes a chemical liquid container as a liquid container, which is integrally formed of plastic. A needle-like tube portion 12 is connected to the upper end side of the container main body 10 for accommodating the medicinal solution. It has been like that. Between the handle 16 formed in the middle of the needle-shaped tube 12 and the container body 10, thin reinforcing ribs 18 are integrally provided at target positions on both sides of the needle-shaped tube 12. Needle tube 12
3 has a shape like an acute angle cut-off, and in particular, the tip portion has a sharp triangular pyramid shape as shown in FIG. As shown in FIG. 3A, a thin portion 20 is formed at the distal end of the flow passage 14 in the needle-shaped tube portion 12, and the flow passage 14 is closed. A thin plate-like gripping piece 22 is integrally provided outside the thin-walled portion 20 at a distal end portion having a circular cross section as shown in FIG. The thin portion 20 is broken by moving it up and down or obliquely, and the flow passage 14 can be opened. The chemical liquid container is filled with a chemical liquid at the time of manufacturing, and the container main body 10 is configured to be able to discharge the content liquid by crushing it with a finger. The chemical solution container can be efficiently manufactured under aseptic conditions by a so-called blow-fill seal method in which the container is continuously formed, filled with the chemical solution, and sealed.
【0006】以上のように構成された実施例の薬液容器
は、針状管部12先端の把持片22を指で摘みねじった
り、上下や左右や斜め等に動かしたりすると薄肉部20
が破損し、流通路14が開封されるので、針状管部12
を輸液容器や点滴回路の側管等に差し込み、容器本体部
10を手の指等で摘み押しつけるようにすと、内容液
(薬液)は輸液容器内や前記側管内に流出し、輸液等と
配合される。内容液を流出させる際親指を容器本体部1
0の底部に掛け、他の指を取手部16に掛けるようにす
ると好都合である。このように、予め配合しておくと変
質するおそれのある薬液を使用の都度簡単に配合するこ
とができる。流通路14を開封する他の手段として、針
状管部に予め傾斜した折れ目を設けておき、使用時にそ
の部分から折り取って針先を形成すると共に流通路先端
を開封するように構成することも考えらるが、このよう
な手段に比し、本実施例では針状管部12の先端部は予
め先鋭な形状をなし鋭利に形成されているので、使用時
の切れ味がよく、また流通路14の開封は特に肉厚を薄
くした薄肉部20を把持片22で破るようにされている
ので、開封し易く使用が容易であるという利点がある。
さらに、本実施例の薬液容器はプラスチックで構成され
ているので、使用後の焼却処分が容易であるという利点
がある。In the liquid medicine container of the embodiment constructed as described above, when the gripping piece 22 at the tip of the needle-like tube portion 12 is pinched and twisted with a finger or moved vertically, horizontally, or diagonally, the thin portion 20 is formed.
Is broken and the flow passage 14 is opened, so that the needle-shaped tubular portion 12
Is inserted into an infusion container or a side tube of an infusion circuit, and the container body 10 is pinched and pressed with a finger or the like, so that the content liquid (chemical solution) flows out into the infusion container or the side tube, and the infusion solution and the like. Be blended. When draining the contents liquid, put your thumb on the container body 1
It is convenient to hang it on the bottom of 0 and to hang another finger on the hand 16. In this way, a chemical solution that may be degraded if previously formulated can be easily blended each time it is used. As another means for opening the flow passage 14, an inclined fold is provided in the needle-like tube portion in advance, and when used, the needle tube portion is cut off to form a needle tip, and the front end of the flow passage is opened. Although it is conceivable that the distal end of the needle-shaped tube portion 12 is sharpened in advance in the present embodiment in comparison with such means, so that the sharpness at the time of use is good, and The opening of the flow passage 14 is particularly advantageous in that the thin portion 20 having a reduced thickness is broken by the gripping piece 22, so that it is easy to open and easy to use.
Further, since the chemical solution container of this embodiment is made of plastic, there is an advantage that incineration after use is easy.
【0007】薬液容器は、従来のこの種容器と同様に医
療用容器として容認されたプラスチックが用いられる。
特に、ポリエチレン、ポリプロピレン等のポリオレフィ
ンは、成形性が優れていることと安全性が確立している
点で好ましい。上記ポリエチレンとしては、エチレンの
ホモポリマーに加え、プロピレン、1−ブテン、4−メ
チル−1−ペンテン、オクテン等のα−オレフィンとの
共重合体も使用可能である。また、該共重合体は直鎖状
であっても分岐鎖状であってもいずれでもよい。ポリエ
チレンは、高密度であるか低密度であるかを問わず、広
い範囲より適宜選択できる。また、上記ポリプロピレン
としては、ホモポリマーあるいはエチレン、1−ブテン
等の少量(一般に10重量%以下、好ましくは5重量%以
下)のオレフィンとの共重合体が利用可能で、医療用容
器として汎用されているグレードのものを用いるのが好
適である。さらに、ポリ1−ブテンやポリ4−メチル−
1−ペンテン等のポリオレフィン、さらにはエチレン・
テトラシクロドデセンコポリマー等の環状オレフィンコ
ポリマーやスチレン・エチレン・ブチレン・スチレンブ
ロックコポリマー等のスチレン系コポリマーも適宜採用
可能である。上記ポリオレフィンは、単独で用いても混
合樹脂または多層成型として用いてもよい。必要に応じ
て、遮光性を付与したり、アルミやシリカ蒸着加工を施
すこともできる。The chemical solution container is made of plastic which is accepted as a medical container, like the conventional container of this kind.
In particular, polyolefins such as polyethylene and polypropylene are preferable because they have excellent moldability and safety is established. As the polyethylene, a copolymer with an α-olefin such as propylene, 1-butene, 4-methyl-1-pentene and octene can be used in addition to a homopolymer of ethylene. Further, the copolymer may be linear or branched. Polyethylene can be appropriately selected from a wide range irrespective of high density or low density. As the polypropylene, a homopolymer or a copolymer with a small amount (generally, 10% by weight or less, preferably 5% by weight or less) of olefin such as ethylene and 1-butene can be used, and is widely used as a medical container. It is preferable to use a grade of the same grade. Furthermore, poly 1-butene and poly 4-methyl-
Polyolefins such as 1-pentene,
A cyclic olefin copolymer such as a tetracyclododecene copolymer and a styrene-based copolymer such as a styrene-ethylene-butylene-styrene block copolymer can be appropriately employed. The polyolefin may be used alone, or as a mixed resin or as a multilayer mold. If necessary, light-shielding properties can be imparted, or aluminum or silica can be evaporated.
【0008】薬液容器内に収容する薬剤としては、特に
限定されない。例えば、生理的食塩液、蒸留水等の溶解
液、ビタミン液、微量元素製剤液、脂肪乳剤液、補正用
塩化カルシウム液等に加え、ヘパリンナトリウム液等の
血液凝固阻止剤、ペントバルビタール、塩酸プロカイン
等の全身または局所麻酔剤、臭化カルシウム等の鎮静
剤、サリチル酸ナトリウム等の解熱鎮痛消炎剤、塩酸ド
パミン等の強心剤、塩酸ニカルジピン等の消化性潰瘍
剤、リン酸ヒドロコルチゾンナトリウム等のホルモン剤
等の薬剤の液を例示できる。[0008] The medicine contained in the chemical solution container is not particularly limited. For example, in addition to physiological saline, a solution such as distilled water, a vitamin solution, a trace element formulation solution, a fat emulsion solution, a calcium chloride solution for correction, etc., a blood coagulation inhibitor such as sodium heparin solution, pentobarbital, procaine hydrochloride Such as systemic or local anesthetics, sedatives such as calcium bromide, antipyretic analgesics and anti-inflammatory agents such as sodium salicylate, inotropics such as dopamine hydrochloride, peptic ulcers such as nicardipine hydrochloride, hormones such as sodium hydrocortisone phosphate, etc. A drug solution can be exemplified.
【0009】上記実施例の容器本体部は図1、図2に示
す形状のものに限定されず、指で押し潰すことにより内
容液を排出できるものであれば種々の形状、構造を採用
できる。針状管部の先端部は図3(ロ)に示すような三
角錐状に限らず、鋭利な他の形状とすることもできる。
また、把持片の形状は図1,図2に示すものに限定され
ず、種々の形状とすることも可能である。要するに、薄
肉部に力を加えて破り得る形状や構造ならばよい。さら
に、本実施例の容器は、薬液に限定されず、使用時配合
する他の液体を収容する場合にも使用できる。例えば、
使用時配合する2液性の接着剤を収容する場合等にも使
用可能である。以上本発明の実施例について説明した
が、本発明はこのような実施例に何ら限定されるもので
はなく、本発明の要旨を逸脱しない範囲において種々な
る態様で実施し得ることはもちろんである。The container main body of the above embodiment is not limited to the shape shown in FIGS. 1 and 2, and various shapes and structures can be adopted as long as the contents can be discharged by crushing with a finger. The tip of the needle-shaped tube is not limited to a triangular pyramid as shown in FIG. 3B, but may have another sharp shape.
Further, the shape of the gripping piece is not limited to those shown in FIGS. 1 and 2 and may be various shapes. In short, any shape or structure that can be broken by applying force to the thin-walled portion may be used. Further, the container of the present embodiment is not limited to a chemical solution, and can be used for storing another liquid to be mixed at the time of use. For example,
It can also be used when accommodating a two-part adhesive to be mixed at the time of use. Although the embodiments of the present invention have been described above, the present invention is not limited to such embodiments at all, and it goes without saying that the present invention can be implemented in various modes without departing from the gist of the present invention.
【0010】[0010]
【発明の効果】本発明は上述のように構成されているの
で、次に記載する効果を奏する。本発明によれば、液体
容器はプラスチックで一体に構成することができるの
で、容器の成形、薬液の充填、溶閉を連続的に行う、い
わゆるブローフィルシール法の採用が可能であり、これ
によって上記作業を無菌状態で能率よく行うことができ
る。また、金属を使用していないので、使用後焼却によ
る廃棄処分が容易である。さらに、針状管部から流出さ
せた薬液を輸液容器や点滴経路の側管に注入し、輸液投
与時に薬液を配合することが可能である。また、針状管
部の先端部は予め先鋭な形状をなし鋭利に形成されてい
るので、使用時の切れ味がよく、また流通路の開封は肉
厚を薄くした薄肉部を把持片を動かして破るようにされ
ているので、開封し易く使用が容易である。Since the present invention is configured as described above, the following effects can be obtained. According to the present invention, since the liquid container can be integrally formed of plastic, it is possible to employ a so-called blow-fill sealing method in which the molding of the container, the filling of the chemical solution, and the sealing process are continuously performed. The above operation can be performed efficiently under aseptic conditions. Further, since no metal is used, disposal by incineration after use is easy. Further, it is possible to inject the drug solution discharged from the needle-like tube portion into the infusion container or the side tube of the drip route, and to mix the drug solution at the time of infusion administration. In addition, the distal end of the needle-shaped tube portion is sharpened in advance and sharply formed, so that the sharpness at the time of use is good, and the opening of the flow passage is performed by moving a gripping piece of a thin portion having a reduced thickness. Because it is made to break, it is easy to open and use.
【図1】本発明の一実施例を示す一部を破断した拡大正
面図である。FIG. 1 is an enlarged front view, partially cut away, showing an embodiment of the present invention.
【図2】同実施例の拡大右側面図である。FIG. 2 is an enlarged right side view of the embodiment.
【図3】 (イ)、(ロ)は図1におけるA部の拡
大断面図とB−B拡大断面図である。FIGS. 3A and 3B are an enlarged sectional view of a portion A in FIG. 1 and an enlarged sectional view taken along a line BB.
8 薬液容器(液体容器) 10 容器本体部 12 針状管部 14 流通路 20 薄肉部 22 把持片 Reference Signs List 8 chemical liquid container (liquid container) 10 container main body 12 needle-like tube 14 flow passage 20 thin part 22 gripping piece
フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) B65D 17/353 (72)発明者 日浦 一 徳島県板野郡松茂町中喜来字中瀬中ノ越 1−37 (72)発明者 長尾 勝美 徳島県徳島市国府町和田字七反田48−1 (72)発明者 四宮 義正 徳島県板野郡藍住町勝瑞東勝地10−7 Fターム(参考) 3E093 AA30 BB13 CC10 DD09 Continuation of the front page (51) Int.Cl. 7 Identification symbol FI Theme coat II (Reference) B65D 17/353 (72) Inventor Kazu Hiura Nakashi Nakagoshi 1-37 (72) ) Inventor Katsumi Nagao 48-1 Nanata, Wada-ku, Kokufu-cho, Tokushima-city, Tokushima (72) Inventor Yoshimasa Shinomiya 10-7 F-term (reference) 3E093 AA30 BB13 CC10 DD09
Claims (3)
管部が突出された液体容器において、前記針状管部は先
端部が先鋭な形状をなし、かつ前記流通路の先端部は薄
肉部によって閉塞されると共に薄肉部には指で把持し得
る把持片が一体に形成されてなり、把持片を動かすこと
によって前記薄肉部を破損し、流通路を開封させ得るよ
うにしたことを特徴とする液体容器。1. A liquid container having a protruding needle-like tubular portion having a flow passage through which a content liquid can flow, wherein the needle-like tubular portion has a sharp tip, and the distal end of the flow passage is A gripping piece that is closed by the thin portion and that can be gripped by a finger is formed integrally with the thin portion, and by moving the gripping piece, the thin portion is damaged and the flow passage can be opened. Characterized liquid container.
容器自体をプラスチックで一体に構成するようにした液
体容器。2. The liquid container according to claim 1, wherein the liquid container itself is integrally formed of plastic.
器において、収容される液体が薬液である液体容器。3. The liquid container according to claim 1, wherein the contained liquid is a chemical.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11069315A JP2000262591A (en) | 1999-03-15 | 1999-03-15 | Liquid container |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11069315A JP2000262591A (en) | 1999-03-15 | 1999-03-15 | Liquid container |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2000262591A true JP2000262591A (en) | 2000-09-26 |
Family
ID=13399012
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP11069315A Pending JP2000262591A (en) | 1999-03-15 | 1999-03-15 | Liquid container |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2000262591A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007319573A (en) * | 2006-06-05 | 2007-12-13 | Fuso Pharmaceutical Industries Ltd | Medicinal liquid container with injection needle |
JP2012135621A (en) * | 2003-04-23 | 2012-07-19 | Otsuka Pharmaceut Factory Inc | Drug solution filling plastic ampoule and process for producing the same |
US9004761B2 (en) | 2006-05-01 | 2015-04-14 | Baxter International Inc. | Multiple chamber container with mistake proof administration system |
-
1999
- 1999-03-15 JP JP11069315A patent/JP2000262591A/en active Pending
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2012135621A (en) * | 2003-04-23 | 2012-07-19 | Otsuka Pharmaceut Factory Inc | Drug solution filling plastic ampoule and process for producing the same |
US8377029B2 (en) | 2003-04-23 | 2013-02-19 | Otsuka Pharmaceutical Factory, Inc. | Drug solution filling plastic ampoule and process for producing the same |
US9004761B2 (en) | 2006-05-01 | 2015-04-14 | Baxter International Inc. | Multiple chamber container with mistake proof administration system |
JP2007319573A (en) * | 2006-06-05 | 2007-12-13 | Fuso Pharmaceutical Industries Ltd | Medicinal liquid container with injection needle |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11534551B2 (en) | Clip syringe | |
US20210283335A1 (en) | Syringe Having Pivoting Arm Plunger Rod | |
US6247617B1 (en) | Single use container for dispensing separately housed sterile compositions | |
US3332418A (en) | Injection site for venoclysis apparatus | |
AU2014292185B2 (en) | Ampoule for a medical liquid, and method for producing an ampoule | |
KR101050254B1 (en) | Container with hollow needle | |
JP4626064B2 (en) | Syringe | |
JPH0527426B2 (en) | ||
US5102408A (en) | Fluid mixing reservoir for use in medical procedures | |
JP2004002271A (en) | Topical styptic medicine composition sealed in flexible container | |
JP2002224195A (en) | Transfusion container | |
JP4854940B2 (en) | Medical multi-chamber container | |
JP2000262591A (en) | Liquid container | |
JP2000070336A (en) | Medicinal liquid storage container and medicinal liquid injecting set using the container | |
JP4210530B2 (en) | Liquid container coupling body and method for manufacturing the liquid container coupling body | |
CN202554467U (en) | Diaphragm type interface for infusion bag | |
JP2004105234A (en) | Pre-filled syringe kit | |
JP3611818B2 (en) | Needleless plastic ampule | |
JP2001187112A (en) | Liquid container with unsealing adapter | |
JPH0299065A (en) | Medical liquid container | |
JPH0759865A (en) | Injection container | |
JP2710414B2 (en) | Injection solution dissolver | |
JP4324287B2 (en) | Transfer needle | |
JP2002210023A (en) | Catheter connection structure of container | |
JP2001017512A (en) | Liquid container with double head needle |